English | Español
Patient Daily | Jan 2, 2026

Five major biopharma acquisitions reshape industry landscape in 2025
Patient Daily | Jan 1, 2026

Study finds key role for NSUN2 protein in development of cardiac hypertrophy
Patient Daily | Jan 1, 2026

Minimal residual disease monitoring offers new approach for breast cancer follow-up
Patient Daily | Jan 1, 2026

Euphorbia neriifolia extract shows promise for heart failure treatment in new study
Patient Daily | Jan 1, 2026

Researchers create functional organoids from adult fat tissue without genetic modification
Patient Daily | Dec 31, 2025

AI accelerates innovation in RNA drug development
Patient Daily | Dec 31, 2025

Trial finds Chinese herbal formula may improve kidney function in diabetic patients
Patient Daily | Dec 31, 2025

Texas House Majority leader Oliverson: 340B is a 'dumpster fire of a program'

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug